About Totipotentrx Cell Therapy Private Limited
Data last updated:
Totipotentrx Cell Therapy Private Limited is a foreign private limited company based in Gurugram, Haryana, India, a subsidiary of Cesca Therapeutics Inc. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 28 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74140HR2011FTC041964. Its GSTIN is 06AADCT7194G1Z3 (Haryana).
The company has an authorised share capital of ₹6.75 Cr and a paid-up capital of ₹45,021. It is led by directors Sunny Omkar Singh and Xiaochun Xu.
Its last annual general meeting (AGM) was held on 29 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 912C 9th Floor Welldone Tech Park Sector 48 Gurugram, Haryana, India – 122001.
As per the financials filed for FY 2023, the company reported a revenue of ₹13,207, a decline of 38% compared to the previous year. For the same year it recorded a net loss of ₹2,707 (net margin -20.5%) and EBITDA of -₹917 (EBITDA margin -6.9%). Revenue has declined at a compounded annual rate (CAGR) of 93% over three years and 81% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed by the company. The company has 4 deals on record (4 secondary share transfers); the latest was in February 2014.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website totipotentrx.com.
Company details
Contact details
Totipotentrx Cell Therapy Private Limited's registered office is in Gurugram, Haryana. Its website is totipotentrx.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address912C 9th Floor Welldone Tech Park Sector 48 Gurugram, Haryana, India – 122001
- IndustryHealthcare, Diagnostic Centers & Pathology Labs, HealthTech & Medical Tech Solutions
To see the full contact details of Totipotentrx Cell Therapy Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Totipotentrx Cell Therapy are professional, scientific and technical, trade and hospital and medical care. In detail, this covers scientific research and development, wholesale trading and other hospital and medical care activities. 3 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | |
| G | Trade | G1 | Wholesale Trading | |
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Totipotentrx Cell Therapy Private Limited, buy the company report.
Financials of Totipotentrx Cell Therapy Private Limited
FY 2023 filings availableTotipotentrx Cell Therapy Private Limited reported revenue of ₹13,207 (down 38% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 81% over five years, including a 38% fall in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹917 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,707 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.9% | ||||
| Net Profit Margin | -20.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Totipotentrx Cell Therapy Private Limited, buy the company report.
Board of directors of Totipotentrx Cell Therapy Private Limited
Totipotentrx Cell Therapy has 2 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunny Omkar Singh | Director | 24 Feb 2020 | 6 Years 8 Months | Current |
| Xiaochun Xu | Director | 02 Jun 2017 | 9 Years 5 Months | Current |
Auditor
Totipotentrx Cell Therapy Private Limited is audited by R BUPATHY & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R BUPATHY & CO | FY 2019 | 000525S |
Shareholding
The shareholding of Totipotentrx Cell Therapy Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Totipotentrx Cell Therapy Private Limited, buy the company report.
Deals & funding
Totipotentrx Cell Therapy Private Limited has 4 deals on record (4 secondary share transfers); the latest was in February 2014.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2014 | Secondary share transfer | Undisclosed | Buyer: Ces Therapeutics Inc Seller: Totipotent RX Corporation USA |
| Jul 2013 | Secondary share transfer | Undisclosed | Buyer: Totipotent RX Corporation USA Seller: MK Alliance Inc |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Totipotent RX Corporation USA, MK Alliance Inc Seller: 2 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Totipotent RX Corporation USA, MK Alliance Inc |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Totipotentrx Cell Therapy Private Limited has 1 court case on record: 1 filed by Totipotentrx Cell Therapy. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Court case (COMI) | Filed by the company against an individual | Disposed |
To see the full case history of Totipotentrx Cell Therapy Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Totipotentrx Cell Therapy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Totipotentrx Cell Therapy Private Limited has a workforce of 2 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Totipotentrx Cell Therapy has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCT7194G1Z3 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Totipotentrx Cell Therapy Private Limited, buy the company report.
Recent activity
Totipotentrx Cell Therapy Private Limited has 13 board changes on record since 2015: 2 appointments and 11 cessations. The latest: Jeffrey Cauble ceased to be Additional Director on 26 Dec 2020.
4 earlier events are in the company report.
Frequently asked questions
Totipotentrx Cell Therapy is an active foreign private limited company based in Gurugram, Haryana, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 28 January 2011 (15+ years old) and is registered under CIN U74140HR2011FTC041964.
Totipotentrx Cell Therapy has 2 current directors:
- Sunny Omkar Singh - Director
- Xiaochun Xu - Director
The latest financial statements of Totipotentrx Cell Therapy on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 29 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Totipotentrx Cell Therapy is 06AADCT7194G1Z3, registered in Haryana.
The CIN (Corporate Identification Number) of Totipotentrx Cell Therapy is U74140HR2011FTC041964. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Totipotentrx Cell Therapy has 1 court case on record: 1 filed by the company.
Totipotentrx Cell Therapy was incorporated on 28 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Totipotentrx Cell Therapy has 4 deals on record (4 secondary share transfers); the latest was in February 2014.
Jeffrey Cauble ceased to be Additional Director on 26 Dec 2020. Sunny Omkar Singh ceased to be Additional Director on 26 Dec 2020. Nitin Chaturvedi ceased to be Alternate Director on 25 Feb 2020. Totipotentrx Cell Therapy has 13 board changes on record in total.
Totipotentrx Cell Therapy can be reached through the website totipotentrx.com. Its registered office is in Gurugram, Haryana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
